While spheroids are gaining traction in research, their use in regulatory toxicology is still evolving. Regulatory agencies like the FDA are increasingly recognizing the importance of more physiologically relevant models. As the technology and methodologies for creating and using spheroids continue to improve, it is likely that they will become a standard tool in regulatory toxicology for evaluating the safety and efficacy of new substances.
